The injectable NAD+ option has a different route and safety context from the nasal spray. Cellular-energy language does not establish a proven treatment for fatigue, cognitive symptoms or aging.
- Format
- Compounded prescription injection
- Price boundary
- Advertised from $93/month
- Evidence basis
- Public catalog plus linked primary guidance
- Review date
- October 8, 2026
What the catalog describes
CoreAge Rx describes NAD+ as Hello Energy and offers an injectable form alongside a nasal form. The website advertises a starting price; the help center provides the route and product category. This review did not independently evaluate the dispensed formulation or measure patient outcomes.[source]
What the evidence establishes
NAD+ has a role in normal cellular processes, but that fact alone cannot demonstrate that this injection improves everyday energy or extends healthy life. We did not verify an independent clinical trial establishing those benefits for the exact CoreAge Rx product.[source]
Questions for the clinical conversation
FDA has warned about ingredients unsuitable for sterile compounding and reports adverse events after NAD+ injectable drugs, including severe chills, shaking and vomiting. The agency’s statement is a category-level concern, not a finding about CoreAge Rx or its pharmacy. It is relevant to questions about sterile preparation and quality.[source]
Practical details to confirm
Ask which pharmacy prepares the medicine, how it is shipped and stored, and who can address an unexpected reaction or damaged delivery. A statement about absorption does not independently establish clinical benefit or eliminate risks associated with injection.[source]
How to weigh this option
Confirm the full plan price and what evaluation is included. Compare the injection and nasal product as different preparations; do not infer equal effect, equivalent doses or a safer route from convenience alone. Unexplained fatigue deserves a clinician’s assessment before being attributed to an assumed NAD+ deficit.
Your questions, answered
Is this review based on using the product?
No. It is based on linked public sources. No firsthand treatment experience, clinical outcome or independent laboratory test is claimed.
Does first placement mean it is best for me?
No. CoreAge Rx is featured commercially. Your needs, the exact product and the evidence should guide a discussion with a qualified professional.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx Help Center: current product catalogProvider formulation and consultation information
- CoreAge Rx: current advertised treatments and pricesProvider starting prices; final plan and billing terms require confirmation
- FDA: ingredients suitable for sterile compoundingAgency reports about NAD+ injectable drugs; not a finding specific to CoreAge Rx